GlassScriptPhysician profile
Marco Funiciello
NPI 1750607321
$1,726.98
in general payments reported to CMS, 2019-2025
17 companies · $507 in 2025
The $507 reported for 2025 was more than what 79% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2021: $258 · 2022: $406 · 2023: $181 · 2024: $208 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $897.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $700.49 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Globus Medical, INC. | $350.66 | 2025 | Senza |
| Si-Bone, INC. | $125.17 | 2019 | |
| Nevro Corp. | $90.66 | 2022 | |
| Ibsa Pharma INC. | $76.61 | 2021-2025 | Tirosint, Flector, Licart |
| Depuy Synthes Sales INC. | $72.09 | 2022-2023 | Monovisc, Orthovisc |
| Horizon Therapeutics Plc | $55.98 | 2021-2022 | |
| Fidia Pharma USA INC. | $44.47 | 2025 | Hymovis, Triluron |
| Bioventus LLC | $34.95 | 2025 | Durolane |
| Vertex Pharmaceuticals Incorporated | $31.05 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $30.48 | 2023-2024 | Euflexxa |
| Allergan, INC. | $29.99 | 2022 | |
| Zimmer Biomet Holdings, INC. | $29.50 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Pfizer INC. | $14.96 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.86 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $13.40 | 2019 | |
| Stimwave Technologies Incorporated | $12.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marco Funiciello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.